Advertisement
Review article| Volume 23, ISSUE 2, P265-293, June 2003

Autoimmune disease as a cause of reproductive failure

  • Neal S Rote
    Correspondence
    Corresponding author: Director of Research, Department of Obstetrics and Gynecology, MetroHealth Medical Center, 2500 MetroHealth Drive, Cleveland, OH 44109
    Affiliations
    Department of Reproductive Biology, Case Western Reserve University School of Medicine, 2500 MetroHealth Drive, Cleveland, OH 44109, USA

    Department of Pathology, Case Western Reserve University School of Medicine, 2500 MetroHealth Drive, Cleveland, OH 44109, USA

    Department of Obstetrics and Gynecology, MetroHealth Medical Center, 2500 MetroHealth Drive, Cleveland, OH 44109, USA
    Search for articles by this author
  • Bradley P Stetzer
    Affiliations
    Department of Reproductive Biology, Case Western Reserve University School of Medicine, 2500 MetroHealth Drive, Cleveland, OH 44109, USA

    Department of Obstetrics and Gynecology, MetroHealth Medical Center, 2500 MetroHealth Drive, Cleveland, OH 44109, USA
    Search for articles by this author
      Autoimmune disease occurs when the immune system responds to self-antigens as if they were foreign. The response may be either humoral, in the form of autoantibody; cellular, with the production of autoreactive T lymphocytes; or a combination of both. Maternal autoimmune disease may affect the mother severely. Some autoantibody-driven diseases may be complicated by transport of the antibody across the placenta, resulting in fetal or newborn symptoms that mimic the maternal disease. This latter group includes myasthenia gravis, Graves' disease, autoimmune forms of thrombocytopenia and anemia, and some complications of systemic lupus erythematosus such as congenital heart block. Relatively few autoimmune diseases, however, result in pregnancy loss or severe pregnancy complications.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Scott J.R
        • Rote N.S
        • Branch D.W
        Immunologic aspects of recurrent abortion and fetal death.
        Obstet Gynecol. 1987; 70: 645-656
        • Branch D.W
        • Scott J.R
        • Kochenour N.K
        • Hershgold E
        Obstetric complications associated with the lupus anticoagulant.
        N Engl J Med. 1985; 313: 1322-1326
        • Derue G.J
        • Englert J.H
        • Harris E.N
        • Gharavi A.E
        • Morgan S.H
        • Hull R.G
        Fetal loss in systemic lupus: association with anticardiolipin antibodies.
        J Obstet Gynaecol. 1985; 5: 207-209
        • Lechner K
        Lupus anticoagulants and thrombosis.
        in: Verstraete M Vermylen J Lijnen R Arnout J Thrombosis and haemostasis. Leuven University Press, Leuven, Belgium1987: 525-547
        • Triplett D.A
        • Brandt J.T
        • Musgrave K.A
        • Orr C.A
        The relationship between lupus anticoagulants and antibodies to phospholipid.
        JAMA. 1988; 259: 550-554
        • Merkel P.A
        • Chang Y.C
        • Pierangeli S.S
        • Convery K
        • Harris E.N
        • Polisson R.P
        The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases.
        Am J Med. 1996; 101: 576-583
        • Cervera R
        • Khamashta M.A
        • Font J
        • Sebastiani G.D
        • Gil A
        • Lavilla P
        • et al.
        Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients.
        Medicine (Baltimore). 1993; 72: 113-124
        • Love P.E
        • Santoro S.A
        Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance.
        Ann Intern Med. 1990; 112: 682-698
        • Alarcón-Segovia D
        • Pérez-Vázquez M.E
        • Villa A.R
        • Drenkard C
        • Cabiedes J
        Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus.
        Semin Arthritis Rheum. 1992; 21: 275-286
        • Wilson W.A
        • Gharavi A.E
        • Koike T
        • Lockshin M.D
        • Branch D.W
        • Piette J.C
        International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome.
        Arthritis Rheum. 1999; 42: 1309-1311
        • Asherson R.A
        • Khamashta M.A
        • Ordi-Ros J
        • Derksen R.H
        • Machin S.J
        • Barquinero J
        • et al.
        The “primary” antiphospholipid syndrome: major clinical and serological features.
        Medicine (Baltimore). 1989; 68: 366-374
        • Ginsberg J.S
        • Wells P.S
        • Brill-Edwards P
        • Donovan D
        • Moffatt K
        • Johnston M
        • et al.
        Antiphospholipid antibodies and venous thromboembolism.
        Blood. 1995; 86: 3685-3691
        • Vianna J.L
        • Khamashta M.A
        • Ordi-Ros J
        • Font J
        • Cervera R
        • Lopez-Soto A
        • et al.
        Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients.
        Am J Med. 1994; 96: 3-9
        • Kent M
        • Alvarez F
        • Vogt E
        • Fyffe R
        • Ng A.K
        • Rote N
        Monoclonal antiphosphatidylserine antibodies react directly with feline and murine central nervous system.
        J Rheumatol. 1997; 24: 1725-1733
        • Kent M.N
        • Alvarez F.J
        • Ng N.K
        • Rote N.S
        Ultrastructural localization of monoclonal antiphospholipid antibody binding to rat brain.
        Exp Neurol. 2000; 163: 173-179
        • Levine J.S
        • Branch D.W
        • Rauch J
        The antiphospholipid syndrome.
        N Engl J Med. 2002; 346: 752-763
        • Pabinger-Fasching I
        Thromboembolism—genetic and acquired risk factors.
        Acta Med Austriaca. 1999; 26: 37-40
        • Chandramouli N.B
        • Rodgers G.M
        Management of thrombosis in women with APS.
        Clin Obstet Gynecol. 2001; 44: 36-47
        • Girolami A
        • Zanon E
        • Zanardi S
        • Saracino M.A
        • Simioni P
        Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies.
        Blood Coagul Fibrinolysis. 1996; 7: 497-501
        • Shapiro S.S
        • Thiagarajan P
        Lupus anticoagulants.
        Prog Hemostasis Thromb. 1982; 6: 263-285
        • Triplett D.A
        Antiphospholipid antibodies and recurrent pregnancy loss.
        Am J Reprod Immunol. 1989; 20: 52-67
        • Triplett D.A
        • Brandt J.T
        Lupus anticoagulants: misnomer, paradox, riddle, epiphenomenon.
        Hematol Pathol. 1988; 2: 121-123
        • Brandt J.T
        • Triplett D.A
        • Alving B
        • Scharrer I
        Criteria for the diagnosis of lupus anticoagulants: an update.
        Thromb Haemost. 1995; 74: 1185-1190
        • Harris E.N
        • Gharavi A.E
        • Boey M.L
        • Patel B.M
        • Mackworth-Young C.G
        • Loizou S
        • et al.
        Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.
        Lancet. 1983; 2: 1211-1214
        • Branch D.W
        • Rote N.S
        • Scott J.R
        Demonstration of lupus anticoagulant antigens using an enzyme-linked immunoadsorbent assay (ELISA).
        Ann NY Acad Sci. 1986; 475: 370-372
        • Branch D.W
        • Rote N.S
        • Scott J.R
        The demonstration of the lupus anticoagulant by an enzyme-linked immunosorbant assay (ELISA).
        Clin Immunol Immunopath. 1986; 39: 296-307
        • Harris E.N
        • Gharavi A.E
        • Patel S.P
        • Hughes G.R.V
        Evaluation of the anti-cardiolipin test: report of an international workshop held 4 April 1986.
        Clin Exp Immunol. 1987; 68: 215-222
        • Loizou S
        • McCrea J.D
        • Rudge A.C
        • Reynolds R
        • Boyle C.C
        • Harris E.N
        Measurement of anticardiolipin antibodies by an enzyme linked immunosorbent assay (ELISA): standardization and quantitation of results.
        Clin Exp Immunol. 1985; 62: 738-745
        • Obringer A.R
        • Rote N.S
        • Walter A
        Antiphospholipid antibody binding to bilayer-coated glass microspheres.
        J Immunol Methods. 1995; 185: 81-93
        • Pierangeli S.S
        • Silva L.K
        • Harris E.N
        A flow cytometric assay for the detection of antiphospholipid antibodies.
        Am Clin Lab. 1999; 18: 18-19
        • Daum G
        Lipids of mitochondria.
        Biochim Biophys Acta. 1985; 822: 1-42
        • Ioannou P.V
        • Golding B.T
        Cardiolipins: their chemistry and biochemistry.
        Prog Lipid Res. 1979; 17: 279-318
        • Harris E.N
        • Gharavi A.E
        • Loizou S
        • Derue G
        • Chan J.K
        • Patel B.M
        • et al.
        Crossreactivity of antiphospholipid antibodies.
        J Clin Lab Immunol. 1985; 16: 1-6
        • Branch D.W
        • Rote N.S
        • Dostal D.A
        • Scott J.R
        Association of lupus anticoagulant with antibody against phosphatidylserine.
        Clin Immunol Immunopath. 1987; 42: 63-75
        • Rote N.S
        • Dostal-Johnson D
        • Branch D.W
        Antiphospholipid antibodies and recurrent pregnancy loss: correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin.
        Am J Obstet Gynecol. 1990; 163: 575-584
        • Dostal-Johnson D
        • Rote N.S
        • Branch D.W
        IgG1 and IgG2 are the predominant subclasses of antiphospholipid antibody in women with the lupus anticoagulant.
        Clin Immun Immunopath. 1990; 54: 309-319
        • Rote N.S
        • Ng A.K
        • Ault K.A
        • Carmody M
        • Dostal-Johnson D.A
        • Mitchell J
        • et al.
        Antiphospholipid antibodies and recurrent pregnancy loss: analysis of monoclonal and polyclonal antiphosphatidylserine antibodies.
        in: Mettler L Billington W.D Reproductive immunology 1989. Elsevier Science Publishers, Amsterdam, the Netherlands1990: 217-226
        • Derksen R.H.W.M
        • Hasselaar P
        • Blokzijl L
        • Gmelig-Meyling F.H.J
        • DeGroot P.G
        Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.
        Ann Rheum Dis. 1988; 47: 364-371
        • Pattison N.S
        • McKay E.J
        • Liggins G.C
        • Lubbe W.F
        Anticardiolipin antibodies: their presence as a marker for lupus anticoagulant in pregnancy.
        NZ Med J. 1987; 100: 61-64
        • Balada E
        • Ordi-Ros J
        • Paredes F
        • Villarreal J
        • Mauri M
        • Vilardell-Tarres M
        Antiphosphatidylethanolamine antibodies contribute to the diagnosis of antiphospholipid syndrome in patients with systemic lupus erythematosus.
        Scand J Rheumatol. 2001; 30: 235-241
        • Galli M
        • Barbui T
        Prevalence of different anti-phospholipid antibodies in systemic lupus erythematosus and their relationship with the antiphospholipid syndrome.
        Clin Chem. 2001; 47: 985-987
        • McNeil H.P
        • Simpson R.J
        • Chesterman C.N
        • Krilis S.A
        Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-Glycoprotein I (apolipoprotein H).
        Proc Natl Acad Sci USA. 1990; 87: 4120-4124
        • Hunt J.E
        • McNeil H.P
        • Morgan G.J
        • Crameri R.M
        • Krilis S.A
        A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection.
        Lupus. 1992; 1: 75-81
        • Galli M
        • Barbui T
        • Zwaal R.F.A
        • Comfurius P
        • Bevers E.M
        Editorial: antiphospholipid antibodies: involvement of protein cofactors.
        Haematologica. 1993; 78: 1-4
        • Galli M
        • Comfurius P
        • Maassen C
        • Hemker H.C
        • DeBaets M.H
        • van Breda-Vriesman P.J.C
        • et al.
        Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor.
        Lancet. 1990; 2: 1544-1557
        • Rauch J
        • Janoff A.S
        Role of monoclonal antibodies in understanding the interactions between anti-phospholipid antibodies and phospholipids.
        in: Harris N Exner T Hughes G.R.V Asherson R.A Phospholipid-binding antibodies. CRC Press, Boca Raton (FL)1991: 108-122
        • Sugi T
        • McIntyre J.A
        Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex.
        Blood. 1995; 86: 3083-3089
        • Nojima J
        • Kuratsune H
        • Suehisa E
        • Futsukaichi Y
        • Yamanishi H
        • Machii T
        • et al.
        Association between the prevalence of antibodies to β2-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications.
        Cllin Chem. 2001; 47: 1008-1015
        • Pengo V
        • Biasiolo A
        • Brocco T
        • Tonetto S
        • Ruffatti A
        Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies.
        Thromb Haemost. 1996; 75: 721-725
        • Matsuura E
        • Igarashi Y
        • Yasuda T
        • Triplett D.A
        • Koike T
        Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.
        J Exp Med. 1994; 179: 457-462
        • Von Landenbert C
        • Lackner K.J
        • von Landenberg P
        • Lang B
        • Schmitz G
        Isolation and characterization of two human monoclonal anti-phospholipid IgG from patients with autoimmune disease.
        J Autoimm. 1999; 13: 215-223
        • Mariette X
        • Levy Y
        • Dubreuil M.L
        • Intrator L
        • Danon F
        • Brouet J.C
        Characterization of a human monoclonal autoantibody directed to cardiolipin/beta 2 glycoprotein I produced by chronic lymphocytic leukaemia B cells.
        Clin Exp Immunol. 1993; 94: 385-390
        • Chukwuocha R.U
        • Hsiao E.T
        • Shaw P
        • Witztum J.L
        • Chen P.P
        Isolation, characterization and sequence analysis of five IgG monoclonal anti-β2-glycoprotein I and anti-prothrombin antigen-binding fragments generated by phage display.
        J Immunol. 1999; 163: 4604-4611
        • Lieby P
        • Soley A
        • Levallois H
        • Hugel B
        • Freyssinet J.-M
        • Cerutti M
        • et al.
        The clonal analysis of anticardiolipin antibodies in a single patient with primary antiphospholipid syndrome reveals an extreme antibody heterogeneity.
        Blood. 2001; 97: 3820-3828
        • Galli M
        Should we include anti-prothrombin antibodies in the screening for the antiphospholipid syndrome?.
        J Autoimm. 2000; 15: 101-105
        • Bruce I.N
        • Clark-Soloninka C.A
        • Spitzer K.A
        • Gladman D.D
        • Urowitz M.B
        • Laskin C.A
        Prevalence of antibodies to β2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
        J Rheumatol. 2000; 27: 2833-2837
        • Detkov Gil-Aguado A
        • Lavilla P
        • Cuesta M.V
        • Fontan G
        • Pascual-Salcedo D
        Do antibodies to beta2-glycoprotein I contribute to the better characterization of the antiphospholipid syndrome?.
        Lupus. 1999; 8: 430-438
        • Horbach D.A
        • van Oort E
        • Derksen R.H.W.M
        • De Groot P.G
        The contribution of anti-prothrombin antibodies to lupus anticoagulant activity.
        Thromb Haemost. 1998; 79: 790-795
        • Galli M
        • Comfurius P
        • Barbui T
        • Zwaal R.F.A
        • Bevers E.M
        Anticoagulant activity of anti-beta-2-glycoprotein I is potentiated by a distinct subgroup of anti-cardiolipin antibodies.
        Thromb Haemost. 1992; 68: 297-300
        • Galli M
        • Beretta G
        • Daldossi M
        • Bevers E.M
        • Barbui T
        Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
        Thromb Haemost. 1997; 77: 486-491
        • Field S.L
        • Chesterman C.N
        • Dai Y.P
        • Hogg P.J
        Lupus antibody bivalency is required to enhance prothrombin binding to phospholipid.
        J Immunol. 2001; 166: 6118-6125
        • Olee T
        • Pierangeli S.S
        • Handley H.H
        • Le D.T
        • Wei X
        • Lai C.-J
        • et al.
        A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice.
        Proc Natl Acad Sci USA. 1996; 93: 8606-8611
        • Arnout J
        The role of beta 2-glycoprotein I dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
        Verh K Acad Geneeskd Belg. 2000; 62: 353-372
        • Branch D.W
        • Scott J.R
        Clinical implications of anti-phospholipid antibodies: the Utah experience.
        in: Harris N Exner T Hughes G.R.V Asherson R.A Phospholipid-binding antibodies. CRC Press, Boca Raton (FL)1991: 335-346
        • Hasegawa I
        • Takakuwa K
        • Goto S
        • Yamada K
        • Sekizuka N
        • Kanazawa K
        • et al.
        Effectiveness of prednisolone/aspirin therapy for recurrent aborters with antiphospholipid antibody.
        Hum Reprod. 1992; 7: 203-207
        • Rai R.S
        • Clifford K
        • Cohen H
        • Regan L
        High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies.
        Hum Reprod. 1995; 10: 3301-3304
        • Lockshin M.D
        • Druzin M.L
        • Goei S
        • Qamar T
        • Magid M.S
        • Jovanovic L
        • et al.
        Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus.
        N Engl J Med. 1985; 313: 152-156
        • Oshiro B.T
        • Silver R.M
        • Scott J.R
        • Yu H
        • Branch D.W
        Antiphospholipid antibodies and fetal death.
        Obstet Gynecol. 1996; 87: 489-493
        • Kochenour N.K
        • Branch D.W
        • Rote N.S
        • Scott J.R
        A new postpartum syndrome associated with antiphospholipid antibodies.
        Obstet Gynecol. 1987; 69: 460-468
        • Branch D.W
        • Andres R
        • Digre K.B
        • Rote N.S
        • Scott J.R
        The association of antiphospholipid antibodies with severe preeclampsia.
        Obstet Gynecol. 1989; 73: 541-545
        • Francois A
        • Freund M
        • Daffos F
        • Remy P
        • Aiach M
        • Jacquot C
        Repeated fetal losses and the lupus anticoagulant.
        Ann Intern Med. 1988; 109: 993-994
        • MacKay A.P
        • Berg C.J
        • Atrash H.K
        Pregnancy-related mortality from preeclampsia and eclampsia.
        Obstet Gynecol. 2001; 97: 533-538
        • Branch D.W
        • Silver R.M
        • Blackwell J.L
        • Reading J.C
        • Scott J.R
        Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience.
        Obstet Gynecol. 1992; 80: 614-620
        • Lima F
        • Khamashta M.A
        • Buchanan N.M
        • Kerslake S
        • Hunt B.J
        • Hughes G.R
        A study of sixty pregnancies in patients with the antiphospholipid syndrome.
        Clin Exp Rheumatol. 1996; 14: 131-136
        • Cowchock F.S
        • Reece E.A
        • Balaban D
        • Branch D.W
        • Plouffe L
        Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.
        Am J Obstet Gynecol. 1992; 166: 1318-1323
        • Kutteh W.H
        Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone.
        Am J Obstet Gynecol. 1996; 174: 1584-1589
        • Rai R
        • Cohen H
        • Dave M
        • Regan L
        Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).
        BMJ. 1997; 314: 253-257
        • Pattison N.S
        • Chamley L.W
        • Birdsall M
        • Zanderigo A.M
        • Liddell H.S
        • McDougall J
        Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial.
        Am J Obstet Gynecol. 2000; 183: 1008-1012
        • Clifford K
        • Rai R
        • Watson H
        • Regan L
        An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases.
        Hum Reprod. 1994; 9: 1328-1332
        • Yetman D.L
        • Kutteh W.H
        Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies.
        Fertil Steril. 1996; 66: 540-546
        • Branch D.W
        • Silver R
        • Pierangeli S
        • van Leeuwen I
        • Harris E.N
        Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome.
        Obstet Gynecol. 1997; 89: 549-555
        • Sletnes K.E
        • Wisloff F
        • Moe N
        • Dale P.O
        Antiphospholipid antibodies in pre-eclamptic women: relation to growth retardation and neonatal outcome.
        Acta Obstet Gynecol Scand. 1992; 71: 112-117
        • Dekker G.A
        • de Vries J.I
        • Doelitzsch P.M
        • Huijgens P.C
        • von Blomberg B.M
        • Jakobs C
        • et al.
        Underlying disorders associated with severe early-onset preeclampsia.
        Am J Obstet Gynecol. 1995; 173: 1042-1048
        • van Pampus M.G
        • Dekker G.A
        • Wolf H
        • Huijgens P.C
        • Koopman M.M
        • von Blomberg B.M
        • et al.
        High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia.
        Am J Obstet Gynecol. 1999; 180: 1146-1150
        • Simmelink M.J.A
        • Horbach D.A
        • Derksen R.H.W.M
        • Meijers J.C.M
        • Bevers E.M
        • Willems G.M
        • et al.
        Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces.
        Br J Haematol. 2001; 113: 621-629
        • Lee R.M
        • Branch D.W
        • Silver R.M
        Immunoglobulin A anti-β2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death.
        Am J Obstet Gynecol. 2001; 185: 748-753
        • Sebastiani G.D
        • Galeazzi M
        • Tincani A
        • Piette J.C
        • Font J
        • Allegri F
        • et al.
        Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations.
        Scan J Rheumatol. 1999; 28: 344-351
        • Frankllin R.D
        • Hollier N
        • Kutteh W.H
        Beta2-glycoprotein I as a marker of antiphospholipid syndrome in women with recurrent pregnancy loss.
        Fertil Steril. 2000; 73: 531-535
        • Gris J.C
        • Quere I
        • Sanmarco M
        • Boutiere B
        • Mercier E
        • Amiral J
        • et al.
        Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss.
        Thromb Haemost. 2000; 84: 228-236
        • Jones D.W
        • Mackie I.J
        • Gallimore M.J
        • Winter M
        Antibodies to factor XII and recurrent fetal loss in patients with the anti-phospholipid syndrome.
        Br J Haematol. 2001; 113: 550-552
        • Branch D.W
        • Porter T.F
        • Rittenhouse L
        • Caritis S
        • Sibai B
        • Hogg B
        • et al.
        Antiphospholipid antibodies in women at risk for preeclampsia.
        Am J Obstet Gynecol. 2001; 184: 825-832
        • Lee R.M
        • Emlen W
        • Scott J.R
        • Branch D.W
        • Silver R.M
        Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome.
        Am J Obstet Gynecol. 1999; 181: 642-648
        • Lynch A.M
        • Rutledge J.H
        • Stephens J.K
        • Murphy J.R
        • Marlar R.A
        • Davila G.H
        • et al.
        Longitudinal measurement of anticardiolipin antibodies during normal pregnancy: a prospective study.
        Lupus. 1995; 4: 365-369
        • Cuadrado M.J
        • Tinahones F
        • Camps M.T
        • de Ramon E
        • Gomez-Zumaquero J.M
        • Mujic F
        • et al.
        Antiphospholipid, anti-beta 2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome.
        Q J Med. 1998; 91: 619-626
        • Rufatti A
        • Scapinello M.P
        • Tonetto S
        • Di Lenardo L
        • Piccoli A
        • Grella P
        • et al.
        Trends in immunoglobulin G anticardiolipin antibodies in ten successful heparin-treated pregnancies.
        Rheumatol Int. 1996; 16: 15-18
        • Caruso A
        • De Carolis S
        • Di Simone N
        Antiphospholipid antibodies in obstetrics: new conplexities and site of action.
        Hum Reprod Update. 1999; 5: 267-276
        • DeWolf F
        • Carreras L.O
        • Moerman P
        • Vermylen J
        • Van Assche A
        • Renaer M
        Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant.
        Am J Obstet Gynecol. 1982; 142: 829-834
        • Out H.J
        • Kooijman C.D
        • Bruinse H.W
        • Derksen R.H.W.M
        Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies.
        Eur J Obstet Gynecol Reprod Biol. 1991; 41: 179-186
        • Nayar R
        • Lage J.M
        Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome: a case report and review of the literature.
        Hum Pathol. 1996; 27: 201-206
        • Erlendsson K
        • Steinsson K
        • Johannsson J.H
        • Geirsson R.T
        Relation of antiphospholipiod antibody and placental bed inflammatory vascular changes to the outcome of pregnancy in successive pregnancies of 2 women with systemic lupus erythematosus.
        J Rheumatol. 1993; 20: 1779-1785
        • Ogishima D
        • Matsumoto T
        • Nakamura Y
        • Yoshida K
        • Kuwabara Y
        Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies.
        Pathol Int. 2000; 50: 224-229
        • Sheppard B.L
        • Bonnar J
        An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation.
        Br J Obstet Gynecol. 1981; 88: 695-705
        • Salafia C.M
        • Cowchock F.S
        Placental pathology and antiphospholipid antibodies: a descriptive study.
        Am J Perinatol. 1997; 14: 435-441
        • Althabe O
        • Labarrere C
        • Telenta M
        Maternal vascular lesions in placentae of small-for-gestational-age infants.
        Placenta. 1985; 6: 265-276
        • Abramowsky C.R
        • Vegas M.E
        • Swinehart G
        • Gyves M.T
        Decidual vasculopathy of the placenta in lupus erythematosus.
        N Engl J Med. 1980; 303: 668-672
        • Meroni P.L
        • Raschi E
        • Camera M
        • Testoni C
        • Nicoletti F
        • Tincani A
        • et al.
        Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome.
        J Autoimmun. 2000; 15: 237-240
        • Shi W
        • Chong B.H
        • Chesterman C.N
        β2-Glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: differences with lupus anticoagulants.
        Blood. 1993; 81: 1255-1262
        • Meroni P.L
        • Del Papa N
        • Raschi E
        • Panzeri P
        • Borghi M.O
        • Tincani A
        • et al.
        β2-Glycoprotein I as a ‘cofactor’ for anti-phospholipid reactivity with endothelial cells.
        Lupus. 1998; 7: S44-S47
        • Kliman H.J
        • Feinman M.A
        • Strauss III, J.F
        Differentiation of human cytotrophoblasts into syncytiotrophoblasts in culture.
        Troph Res. 1987; 2: 407-421
        • Ran S
        • Gao B
        • Duffy S
        • Watkins L
        • Rote N
        • Thorpe P.E
        Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumor vasculature.
        Cancer Res. 1998; 58: 4646-4653
        • Lyden T.W
        • Vogt E
        • Ng A.K
        • Johnson P.M
        • Rote N.S
        Monoclonal antiphospholipid antibody reactivity against human placental trophoblast.
        J Reprod Immunol. 1992; 22: 1-14
        • Rote N.S
        • Chang J
        • Katsuragawa H
        • Ng A.K
        • Lyden T.W
        • Mori T
        Expression of phosphatidylserine-dependent antigens on the surface of differentiating BeWo human choriocarcinoma cells.
        Am J Reprod Immunol. 1995; 33: 114-121
        • Vogt E
        • Ng A.K
        • Rote N.S
        Antiphosphatidylserine antibody removes annexin V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation.
        Am J Obstet Gynecol. 1997; 177: 964-972
        • Rand J.H
        • Wu X.-X
        • Guller S
        • Gil J
        • Guha A
        • Scher J
        • et al.
        Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion.
        Am J Obstet Gynecol. 1994; 171: 1566-1572
        • Krikun G
        • Lockwood C.J
        • Wu X.-X
        • Zhou X.-D
        • Guller S
        • Calandri C
        • et al.
        The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation.
        Placenta. 1994; 15: 601-612
        • Chamley L.W
        • Pattison N.S
        • McKay E.J
        Elution of anticardiolipin antibodies and their co-factor beta-2-glycoprotein I from placentae of patients with a poor obstetric history.
        J Reprod Immunol. 1993; 25: 209-220
        • Katano K
        • Aoki K
        • Ogasawara M
        • Sasa H
        • Hayashi Y
        • Kawamura M
        • et al.
        Specific antiphospholipid antibodies eluted from placentae of pregnant women with aPL-positive sera.
        Lupus. 1995; 4: 304-308
        • Hasegawa I
        • Takakuwa K
        • Adachi S
        • Kanazawa K
        Cytotoxic antibody against trophoblast and lymphoctyes present in pregnancy with intrauterine fetal growth retardation and its relation to anti-phospholipid antibody.
        J Reprod Immunol. 1990; 17: 127-139
        • Donohoe S
        • Kingdom J.C
        • Mackie I.J
        Affinity purified human antiphospholipid antibodies bind normal term placenta.
        Lupus. 1999; 8: 525-531
        • Katsuragawa H
        • Rote N.S
        • Inoue T
        • Narukawa S
        • Kanzaki H
        • Mori T
        Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts.
        Am J Obstet Gynecol. 1995; 172: 1592-1597
        • Blank M
        • Tincani A
        • Shoenfeld Y
        Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies.
        J Rheumatol. 1994; 21: 100-104
        • Lochkshin M.D
        Pregnancy loss and antiphospholipid antibodies.
        Lupus. 1998; 7: S86-S89
        • Piona A
        • La Rosa L
        • Tincani A
        • Faden D
        • Magro G
        • Grasso S
        • et al.
        Placental thrombosis and fetal loss after passive transfer of mouse lupus monoclonal or human polyclonal anti-cardiolipin antibodies in pregnant naı̈ve BALB/c mice.
        Scand J Immunol. 1995; 41: 427-432
        • Vogt E
        • Ng A.K
        • Rote N.S
        A model for the antiphospholipid antibody syndrome: monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice.
        Am J Obstet Gynecol. 1996; 174: 700-707
        • Schick P.K
        • Kurica K.B
        • Chacko G.K
        Localization of phosphatidylethanolamine and phosphatidylserine in the human platelet plasma membrane.
        J Clin Invest. 1976; 57: 1221-1226
        • Nakashima S
        • Suganuma A
        • Matsui A
        • Nozawa Y
        Thrombin induces a biphasic 1,2-diacyl glycerol production in human platelets.
        Biochem J. 1991; 275: 355-361
        • Schroit A.J
        • Bloy C
        • Connor J
        • Cartron J.-P
        Involvement of Rh blood group polypeptides in the maintenance of aminophospholipid asymmetry.
        Biochem. 1990; 29: 10303-10306
        • Zachowski A
        • Herrmann A
        • Paraf A
        • Devaux P.F
        Phospholipid outside-inside translocation in lymphocyte plasma membranes is a protein-mediated phenomenon.
        Biochim Biophys Acta. 1987; 897: 197-200
        • Mietto L
        • Boarato E
        • Toffano G
        • Bruni A
        Internalization of phosphatidylseine by adherent and non-adherent rat mononuclear cells.
        Biochim Biophys Acta. 1989; 1013: 1-6
        • Martin O.C
        • Pegano R.E
        Transbilayer movement of fluorescent analogs of phosphatidylserine and phosphatidylethanol-amine at the plasma membrane of cultured cells: evidence for a protein-mediated and ATP-dependent process(es).
        J Biol Chem. 1987; 262: 5890-5898
        • Seigneuret M
        • Devaux P.F
        ATP-dependent asymmetric distribution of spin-labelled phospholipids in the erythrocyte membrane: relation to shape change.
        Proc Natl Acad Sci USA. 1984; 81: 3751-3755
        • Zachowski A
        • Favre E
        • Cribier S
        • Herve P
        • Devaux P.F
        Outside-inside translocation of aminophospholipids in the human erythrocyte membrane is mediated by a specific enzyme.
        Biochemistry. 1986; 25: 2585-2590
        • Beleznay Z
        • Zachowski A
        • Devaux P.F
        • Navazo M.P
        • Ott P
        ATP-dependent aminophospholipid translocation in erythrocyte vesicles: stoichiometry of transport.
        Biochemistry. 1993; 32: 3146-3152
        • Moriyama Y
        • Nelson N
        Purification and properties of a vanadate- and N-ethylmaleimide-sensitive ATPase from chromaffin granule membranes.
        J Biol Chem. 1988; 263: 8521-8527
        • Morrot G
        • Zachowski A
        • Devaux P.F
        Partial purification and characterization of the human erythrocyte Mg2+-ATPase: a candidate aminophospholipid translocase.
        FEBS Lett. 1990; 266: 29-32
        • Ravanat C
        • Archipoff G
        • Beretz A
        • Freund G
        • Cazenave J.P
        • Freyssinet J.M
        Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance of endothelial cells.
        Biochem J. 1992; 282: 7-13
        • Auland M.E
        • Roufogalis B.D
        • Devaux P.F
        • Zachowski A
        Reconstitution of ATP-dependent aminophospholipid translocation in proteoliposome.
        Proc Natl Acad Sci USA. 1994; 91: 10938-10942
        • Gaffet P
        • Bettache N
        • Bienvenue A
        Transverse redistribution of phospholipids during human platelet activation: evidence for a vectorial outflux specific to aminophospholipids.
        Biochemistry. 1995; 34: 6762-6769
        • Oshry L
        • Meers P
        • Mealy T
        • Tauber A.I
        Annexin-mediated membrane fusion of human neutrophil plasma membranes and phospholipid vesicles.
        Biochim Biophys Acta. 1991; 1066: 239-244
        • Fadok V.A
        • Voelker D.R
        • Campbell P.A
        • Cohen J.J
        • Bratton D.L
        • Henson P.M
        Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages.
        J Immunol. 1992; 148: 2207-2216
        • McEvoy L
        • Williamson P
        • Schlegel R.A
        Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages.
        Proc Natl Acad Sci USA. 1986; 83: 3311-3315
        • Koopman G
        • Reutelingsperger C.P
        • Kuijten G.A
        • Keehnen R.M
        • Pals S.T
        • van Oers M.H
        Annexin V for flow cytometric detection of phosphatidyserine expression on B cells undergoing apoptosis.
        Blood. 1994; 84: 1415-1420
        • Rote N.S
        • Ng A.K
        • Dostal-Johnson D.A
        • Nicholson S.L
        • Siekman R
        Immunologic detection of phosphatidylserine externalization during thrombin-induced platelet activation.
        Clin Immunol Immunopath. 1993; 66: 193-200
        • Bevers E.M
        • Galli M
        • Barbui T
        • Comfurius P
        • Zwaal R.F.A
        Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin.
        Thromb Haemost. 1991; 66: 629-632
        • Thiagarajan P
        • Tait J.F
        Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets.
        J Biol Chem. 1990; 265: 17420-17423
        • Zwaal R.F.A
        • Bevers E.M
        • Comfurius P
        • Rosing J
        • Tilly R.H
        • Verhallen P.F
        Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanisms and physiological significance.
        Mol Cell Biochem. 1989; 91: 23-31
        • Sessions A
        • Horowitz A.F
        Myoblast aminophospholipid asymmetry differs from that of fibroblasts.
        FEBS Lett. 1981; 134: 75-78
        • Sessions A
        • Horowitz A.F
        Differentiation related differences in the plasma membrane phospholipid asymmetry of myogenic and fibrogenic cells.
        Biochim Biophys Acta. 1983; 728: 103-111
        • Adler R.R
        • Ng A.K
        • Rote N.S
        Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR.
        Biol Reprod. 1995; 53: 905-910
        • Di Simone N
        • Caliandro D
        • Castellani R
        • Ferrazzani S
        • De Carolis
        • Caruso A
        Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome.
        Hum Reprod. 1999; 14: 489-495
        • Di Simone N
        • Castellani R
        • Caliandro D
        • Caruso A
        Antiphospholipid antibodies regulate the expression of trophoblast cell adhesion molecules.
        Fertil Steril. 2002; 77: 805-811
        • Rand J.H
        • Wu X
        • Andree H.A.M
        • Lockwood C.J
        • Guller S
        • Scher J
        • et al.
        Pregnancy loss in the antiphospholipid-antibody syndrome: a possible thrombogenic mechanism.
        N Engl J Med. 1997; 337: 154-160
        • Rote N.S
        • Das M
        • Xu B
        • Lin L
        • Kumar N
        Monoclonal antiphospholipid and anti-annexin A5 antibodies prevent intercellular fusion in a model of human villous cytotrophoblast.
        Eur J Clin Invest. 2003; 33: 62
        • Di Simone N
        • Castellani R
        • Caliandro D
        • Caruso A
        Monoclonal anti-annexin V antibody inhibits trophoblast gonadotropin secretion and induces syncytiotrophoblast apoptosis.
        Biol Reprod. 2001; 65: 1766-1770
        • Kaburaki J
        • Kuwana M
        • Yamamoto M
        • Kawai S
        • Ikeda Y
        Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus.
        Am J Hematol. 1997; 54: 209-213
        • Matsuda J
        • Saitoh N
        • Gohchi K
        • Gotoh M
        • Tsukamoto M
        Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody.
        Am J Hematol. 1994; 47: 56-58
        • Wang X
        • Campos B
        • Kaetzel M.A
        • Dedman J.R
        Annexin V is critical in the maintenance of murine placental integrity.
        Am J Obstet Gynecol. 1999; 180: 1008-1016
        • Roberts J.M
        Preeclampsia: what we know and what we do not know.
        Semin Perinatol. 2000; 24: 24-28
        • Lyall F
        • Bulmer J.N
        • Kelly H
        • Duffie E
        • Robson S.C
        Human trophoblast invasion and spiral artery transformation.
        Am J Pathol. 1999; 154: 1105-1114
        • Damsky Ch
        • Librach C
        • Lim K.H
        • Fitzgerald M.L
        • McMaster M.T
        • Janatpour M
        • et al.
        Integrin switching regulates normal trophoblast invasion.
        Development. 1994; 120: 3657-3666
        • Zhou Y
        • Fisher S.J
        • Janatpour M
        • Genbacev O
        • Dejana E
        • Wheelock M
        Human cytotrophoblasts adopt a vascular phenotype as they differentiate.
        J Clin Invest. 1997; 99: 2139-2151
        • Katsuragawa H
        • Kanzaki H
        • Inoue T
        • Hirano T
        • Mori T
        • Rote N.S
        Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion.
        Biol Reprod. 1997; 56: 50-58
        • Silver R.K
        • MacGregor S.N
        • Sholl J.S
        • Hobart J.M
        • Neerhof M.G
        • Ragin A
        Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients.
        Am J Obstet Gynecol. 1993; 169: 1411-1417
        • Granger K.A
        • Farquharson R.G
        Obstetric outcome in antiphospholipid syndrome.
        Lupus. 1997; 6: 509-513
        • Ginsberg J.S
        • Greer I
        • Hirsh J
        Use of antithrombotic agents during pregnancy.
        Chest. 2001; 119: 122S-131S
        • Ruffatti A
        • Orsini A
        • Di Lenardo L
        • Nardelli G.B
        • Patrassi G.M
        • Truscia D
        • et al.
        A prospective study of fifty-three consecutive calcium heparin treated pregnancies in patients with antiphospholipid antibody-related fetal loss.
        Clin Exp Rheumatol. 1997; 15: 499-505
        • Backos M
        • Rai R
        • Baxter N
        • Chilcott I.T
        • Cohen H
        • Regan L
        Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
        Br J Obstet Gynaecol. 1999; 106: 102-107